PharmaVitae explores Regeneron’s prescription pharmaceutical performance and outlook over 2019–29.
Snapshot Overview – Regeneron’s prescription pharmaceutical business has solid near-term growth but will see a long-term decline due to Eylea biosimilars. Key themes – [1] Eylea sales will peak in 2022 as biosimilar competition begins in the US in 2023 [2] Collaboration revenue will continue to grow, driven by Dupixent and international Eylea sales.
Model updates (5 May 2020)
Praluent forecast added due to restructuring of Sanofi agreement Libtayo forecast adjusted higher due to recent trial data from non-small cell lung cancer and basal cell carcinoma.
Model updates (6 February 2020)
Eylea forecast adjusted higher due to continued share gains.
Model updates (8 November 2019)
Eylea forecast adjusted higher due to continued market share gains in wet AMD and diabetic eye conditions Libtayo forecast adjusted higher due to continued growth in advanced cutaneous squamous cell carcinoma.
Model updates (12 July 2019)
Libtayo sales adjusted higher due to stronger than expected launch.
Our reports have been used by over 10K customers, including:
The global drug screening market is projected to reach USD 10.0 billion by 2025, from USD 4.5 billion in 2020, at a CAGR of 17.3% during the forecast period. Market growth can be largely attributed to factors such as the rising drug & alcohol consumption, the enforcement of stringent laws mandating drug and alcohol testing, government funding...
Tuberculosis - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis - Pipeline Review, H2 2020, provides an overview of the Tuberculosis (Infectious Disease) pipeline landscape. Tuberculosis, commonly known as TB, is a bacterial infection...
Glucagon Like Peptide 2 Receptor - Pipeline Review, H2 2020 Summary Glucagon Like Peptide 2 Receptor (GLP2R) - Glucagon-like peptide 2 receptor (GLP-2R) is a protein encoded by the GLP2R gene. GLP2R, a G protein-coupled receptor superfamily member is expressed in the gut. GLP2 stimulates intestinal...
Anti-obesity Prescription Drugs Market Research Report by Drug Class (Bupropion and Naltrexone, Liraglutide, Lorcaserin, Orlistat, and Phentermine and Topiramate), by Age Group (Adult and Pediatric), by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Anti-obesity Prescription...
Injectable Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Injectable Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Injectable Drug Delivery Devicess pipeline products with...
Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Transmucosal Drug Delivery Devicess pipeline products...
Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2020, provides an overview of the Human Papillomavirus (HPV) Associated Cancer (Oncology)...
The global osteoarthritis therapeutics market is projected to reach USD 11.0 billion by 2025 from USD 7.3 billion in 2020, at a CAGR of 8.7% from 2020 to 2025. The growth of this market is driven significant adoption of pain medications, increasing prevalence of osteoarthritis, growing population susceptible to osteoarthritis, and rising number...
The North America dermatology treatment devices market is expected to reach US$ 3,908.11 million in 2027 from US$ 2,310.03 million in 2019. The market is estimated to grow with a CAGR of 7.0% from 2020 to 2027. The growth of this market is attributed to the key driving factors such as growing incidences of skin disorders and skin cancer...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.